Apr 28, 2022 / 06:00AM GMT
Dennis Höjer - Carasent ASA - CEO
Hello, everyone, and welcome to today's presentation of our first-quarter report of Carasent. My name is Dennis Höjer, and I will walk through the first half of this report. And the agenda for today is, of course, to mention some highlights, the business and market updates. We will go with some financial review and the outlook.
So a quick summary of the first quarter for Carasent, we had a revenue growth of a total of 59%, of this is 22% coming from organic growth. Although 25% of our recurring growth is coming from organic growth. And we are doing some changes in our reporting structure in order to reflect our new organization [on forth]. And also, Webdoc X and the initiative to adapt by book into the Norwegian market is progressing according to plan. The acquisition of Medrave was closed in early January this year.
So a quick glance of Carasent today. As many of you probably know by now, our main focus is cloud-based proprietary medical record software solutions addressing the private health care segment within Scandinavia. We have
Q1 2022 Carasent ASA Earnings Call Transcript
Apr 28, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers